171 related articles for article (PubMed ID: 22705596)
1. CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis.
Brown R; Kabani K; Favaloro J; Yang S; Ho PJ; Gibson J; Fromm P; Suen H; Woodland N; Nassif N; Hart D; Joshua D
Blood; 2012 Sep; 120(10):2055-63. PubMed ID: 22705596
[TBL] [Abstract][Full Text] [Related]
2. Has the T cell bitten off more than it can chew?
Cook G
Blood; 2012 Sep; 120(10):1966-7. PubMed ID: 22956525
[No Abstract] [Full Text] [Related]
3. Different functional outcomes of intercellular membrane transfers to monocytes and T cells.
HoWangYin KY; Alegre E; Daouya M; Favier B; Carosella ED; LeMaoult J
Cell Mol Life Sci; 2010 Apr; 67(7):1133-45. PubMed ID: 20238479
[TBL] [Abstract][Full Text] [Related]
4. HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.
Rizzo R; Audrito V; Vacca P; Rossi D; Brusa D; Stignani M; Bortolotti D; D'Arena G; Coscia M; Laurenti L; Forconi F; Gaidano G; Mingari MC; Moretta L; Malavasi F; Deaglio S
Haematologica; 2014 May; 99(5):888-96. PubMed ID: 24362551
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic and genotypic characterisation of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45RO (UCHL-1).
Menke DM; Horny HP; Griesser H; Atkinson EJ; Kaiserling E; Kyle RA
J Clin Pathol; 1998 Jun; 51(6):432-7. PubMed ID: 9771441
[TBL] [Abstract][Full Text] [Related]
6. Characterization of antiserum against myeloma cells.
Cawley LP; Goodwin WL; Minard BJ
Cancer Res; 1973 Jan; 33(1):17-22. PubMed ID: 4629871
[No Abstract] [Full Text] [Related]
7. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.
Maki G; Hayes GM; Naji A; Tyler T; Carosella ED; Rouas-Freiss N; Gregory SA
Leukemia; 2008 May; 22(5):998-1006. PubMed ID: 18288133
[TBL] [Abstract][Full Text] [Related]
8. Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro.
Frassanito MA; Ruggieri S; Desantis V; Di Marzo L; Leone P; Racanelli V; Fumarulo R; Dammacco F; Vacca A
Eur J Haematol; 2015 Jul; 95(1):65-74. PubMed ID: 25409753
[TBL] [Abstract][Full Text] [Related]
9. HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?
Erikci AA; Karagoz B; Ozyurt M; Ozturk A; Kilic S; Bilgi O
Hematology; 2009 Apr; 14(2):101-5. PubMed ID: 19298722
[TBL] [Abstract][Full Text] [Related]
10. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
[TBL] [Abstract][Full Text] [Related]
11. In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance.
Loumagne L; Baudhuin J; Favier B; Montespan F; Carosella ED; Rouas-Freiss N
Int J Cancer; 2014 Nov; 135(9):2107-17. PubMed ID: 24623585
[TBL] [Abstract][Full Text] [Related]
12. The production of interferon by malignant plasma cells from patients with multiple myeloma.
Epstein LB; Salmon SE
J Immunol; 1974 Mar; 112(3):1131-8. PubMed ID: 4359784
[No Abstract] [Full Text] [Related]
13. Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease.
Perez-Andres M; Almeida J; Martin-Ayuso M; De Las Heras N; Moro MJ; Martin-Nuñez G; Galende J; Cuello R; Abuín I; Moreno I; Domínguez M; Hernandez J; Mateo G; San Miguel JF; Orfao A
Int J Cancer; 2009 Jan; 124(2):367-75. PubMed ID: 19003959
[TBL] [Abstract][Full Text] [Related]
14. Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell-recruiting Antibody Optimized for Cytotoxicity and Cytokine Release.
Zuch de Zafra CL; Fajardo F; Zhong W; Bernett MJ; Muchhal US; Moore GL; Stevens J; Case R; Pearson JT; Liu S; McElroy PL; Canon J; Desjarlais JR; Coxon A; Balazs M; Nolan-Stevaux O
Clin Cancer Res; 2019 Jul; 25(13):3921-3933. PubMed ID: 30918018
[TBL] [Abstract][Full Text] [Related]
15. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
[TBL] [Abstract][Full Text] [Related]
16. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.
Chng WJ; Schop RF; Price-Troska T; Ghobrial I; Kay N; Jelinek DF; Gertz MA; Dispenzieri A; Lacy M; Kyle RA; Greipp PR; Tschumper RC; Fonseca R; Bergsagel PL
Blood; 2006 Oct; 108(8):2755-63. PubMed ID: 16804116
[TBL] [Abstract][Full Text] [Related]
17. CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemia.
Neumann F; Pfreundschuh M; Preuss KD; Schormann C; Zwick C; Murawski N; Kubuschok B
Int J Cancer; 2015 Sep; 137(5):1076-84. PubMed ID: 25677163
[TBL] [Abstract][Full Text] [Related]
18. Changes in the pattern of TCR V beta repertoire expression after bone marrow transplant is linked to the HLA haplotype in humans.
Lonial S; Bomberger C; Waller EK
Br J Haematol; 2001 Apr; 113(1):224-30. PubMed ID: 11328305
[TBL] [Abstract][Full Text] [Related]
19. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
20. Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.
Leo R; Boeker M; Peest D; Hein R; Bartl R; Gessner JE; Selbach J; Wacker G; Deicher H
Ann Hematol; 1992 Mar; 64(3):132-9. PubMed ID: 1373957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
